# Novavax Inc. (NVAX) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | $453M |
| 2024 | -$249M |
| 2023 | -$567M |
| 2022 | -$645M |
| 2021 | -$1.69B |
| 2020 | -$417M |
| 2019 | -$121M |
| 2018 | -$174M |
| 2017 | -$172M |
| 2016 | -$269M |
| 2015 | -$157M |
| 2014 | -$84M |
| 2013 | -$52M |
| 2012 | -$30M |
| 2011 | -$22M |
| 2010 | -$38M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$15M |
| 2025-09-30 | -$178M |
| 2025-06-30 | $101M |
| 2025-03-31 | $516M |
| 2024-09-30 | -$134M |
| 2024-06-30 | $161M |
| 2024-03-31 | -$145M |
| 2023-09-30 | -$126M |
| 2023-06-30 | $55M |
| 2023-03-31 | -$313M |
| 2022-09-30 | -$127M |
| 2022-06-30 | -$483M |
| 2022-03-31 | $209M |
| 2021-09-30 | -$307M |
| 2021-06-30 | -$346M |
| 2021-03-31 | -$209M |
| 2020-09-30 | -$194M |
| 2020-06-30 | -$17M |
| 2020-03-31 | -$23M |
| 2019-09-30 | -$15M |
| 2019-06-30 | -$37M |
| 2019-03-31 | -$40M |
| 2018-09-30 | -$42M |
| 2018-06-30 | -$42M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/NVAX/operating-income)
